Literature DB >> 15246113

The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices.

Mark Anthony Laudadio1, Caterina Psarropoulou.   

Abstract

The effects of the A(3) adenosine receptor agonist 2-Cl-IB-MECA were tested on epileptiform field potentials recorded in the CA3 area of postnatal days 10-20 immature hippocampal slices, during perfusion with the GABA(A) receptor antagonist bicuculline (10 microM). Evoked potentials: 2-Cl-IB-MECA (1-50 microM, n = 17) had consistently excitatory effects, blocked by the A(3) receptor antagonist MRS 1220 (1 microM, n = 7), but not occluded in the presence of the A(1) antagonist DPCPX (1 microM, n = 12) or the A(2A) antagonist ZM-241385 (0.1 microM, n = 12). 2-Cl-IB-MECA reversed the inhibitory effects (n = 5) of the adenosine uptake blocker nitrobenzylthioinosine (NBTI, 50 microM), but did not increase its excitatory effects (n = 19). Spontaneous discharges: 2-Cl-IB-MECA (1 microM) induced them or increased their frequency in 14/30 slices, an effect reversed by MRS 1220 (n = 3), and observed also following pre-perfusion with DPCPX (n = 11), ZM-241385 (n = 11) or both (n = 10). In the presence of the A(1) antagonist DPCPX, NBTI increased the frequency of spontaneous discharges, an effect partially reversed by MRS 1220 (n = 8), thus suggesting that a rise in endogenous adenosine during disinhibition may activate A(3) receptors. In conclusion, these findings suggest strongly that activation of A(3) receptors, following a rise in endogenous adenosine (i.e. during seizures, hypoxia), facilitates excitation, thus limiting the known inhibitory and/or neuroprotective effects of adenosine in immature brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246113     DOI: 10.1016/j.eplepsyres.2004.03.005

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  10 in total

1.  A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro.

Authors:  Anna Maria Pugliese; Elisabetta Coppi; Giampiero Spalluto; Renato Corradetti; Felicita Pedata
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  Anticonvulsant action of 2-chloroadenosine against pentetrazol-induced seizures in immature rats is due to activation of A1 adenosine receptors.

Authors:  P Mareš
Journal:  J Neural Transm (Vienna)       Date:  2010-08-31       Impact factor: 3.575

Review 3.  Adenosine receptors and epilepsy: current evidence and future potential.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

4.  Identification of the functional expression of adenosine A3 receptor in pancreas using transgenic mice expressing jellyfish apoaequorin.

Authors:  Kazuya Yamano; Katsuhiro Mori; Ryosuke Nakano; Machi Kusunoki; Miho Inoue; Mitsuo Satoh
Journal:  Transgenic Res       Date:  2007-03-27       Impact factor: 3.145

5.  The role of ATP and adenosine in the brain under normoxic and ischemic conditions.

Authors:  F Pedata; A Melani; A M Pugliese; E Coppi; S Cipriani; C Traini
Journal:  Purinergic Signal       Date:  2007-10-11       Impact factor: 3.765

6.  Hide and seek: a comparative autoradiographic in vitro investigation of the adenosine A3 receptor.

Authors:  D Haeusler; L Grassinger; F Fuchshuber; W J Hörleinsberger; R Höftberger; I Leisser; F Girschele; K Shanab; H Spreitzer; W Gerdenitsch; M Hacker; W Wadsak; Markus Mitterhauser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-05       Impact factor: 9.236

7.  2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines.

Authors:  Jana Kotulova; Katerina Lonova; Agata Kubickova; Jana Vrbkova; Pavla Kourilova; Marian Hajduch; Petr Dzubak
Journal:  Int J Mol Med       Date:  2022-01-18       Impact factor: 4.101

Review 8.  Role of Adenosine in Epilepsy and Seizures.

Authors:  Fabio C Tescarollo; Diogo M Rombo; Lindsay K DeLiberto; Denise E Fedele; Enmar Alharfoush; Ângelo R Tomé; Rodrigo A Cunha; Ana M Sebastião; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2020-06-04

Review 9.  Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.

Authors:  Wiwin Is Effendi; Tatsuya Nagano; Kazuyuki Kobayashi; Yoshihiro Nishimura
Journal:  Cells       Date:  2020-03-24       Impact factor: 6.600

Review 10.  Therapeutic Potential of Highly Selective A3 Adenosine Receptor Ligands in the Central and Peripheral Nervous System.

Authors:  Elisabetta Coppi; Federica Cherchi; Martina Venturini; Elena Lucarini; Renato Corradetti; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Felicita Pedata; Anna Maria Pugliese
Journal:  Molecules       Date:  2022-03-15       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.